Weiss Ratings Reiterates Sell (D-) Rating for Health Catalyst (NASDAQ:HCAT)

Key Points

• Weiss Ratings has reaffirmed a "Sell (D-)" rating for Health Catalyst (NASDAQ: HCAT), indicating ongoing concerns about the company's stock performance.
• Multiple analysts have lowered their price targets for Health Catalyst, with estimates ranging from $3.50 to $5.00, reflecting a bearish outlook on the company's future.
• Despite a challenging market, institutional investors hold 85% of Health Catalyst's stock, demonstrating significant institutional confidence amidst the negative ratings.

Health Catalyst (NASDAQ:HCAT - Get Free Report)'s stock had its "sell (d-)" rating reaffirmed by stock analysts at Weiss Ratings in a report issued on Wednesday,Weiss Ratings reports.

A number of other equities research analysts have also commented on HCAT. Canaccord Genuity Group lowered their price target on shares of Health Catalyst from $9.00 to $5.00 and set a "buy" rating for the company in a report on Friday, August 29th. Stifel Nicolaus lowered their price target on shares of Health Catalyst from $5.50 to $4.50 and set a "hold" rating for the company in a report on Friday, August 8th. Wells Fargo & Company lowered their price target on shares of Health Catalyst from $10.00 to $6.00 and set an "overweight" rating for the company in a report on Monday, August 11th. Cantor Fitzgerald reiterated a "neutral" rating and set a $4.00 price target on shares of Health Catalyst in a report on Tuesday. Finally, Citigroup lowered shares of Health Catalyst from a "buy" rating to a "neutral" rating and lowered their price target for the company from $6.50 to $3.50 in a report on Friday, August 8th. Three analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the company has an average rating of "Hold" and an average target price of $4.55.

Health Catalyst Price Performance

Shares of Health Catalyst stock opened at $2.85 on Wednesday. The company has a fifty day moving average of $3.15 and a 200-day moving average of $3.68. Health Catalyst has a 52-week low of $2.52 and a 52-week high of $9.24. The company has a debt-to-equity ratio of 0.44, a quick ratio of 1.83 and a current ratio of 1.83. The stock has a market capitalization of $200.55 million, a price-to-earnings ratio of -1.89 and a beta of 1.62.

Institutional Inflows and Outflows

Several institutional investors have recently added to or reduced their stakes in the stock. First Light Asset Management LLC increased its stake in shares of Health Catalyst by 17.2% in the 2nd quarter. First Light Asset Management LLC now owns 12,230,181 shares of the company's stock worth $46,108,000 after acquiring an additional 1,793,374 shares in the last quarter. Primecap Management Co. CA increased its stake in shares of Health Catalyst by 3.8% in the 1st quarter. Primecap Management Co. CA now owns 2,005,116 shares of the company's stock worth $9,083,000 after acquiring an additional 72,499 shares in the last quarter. Whetstone Capital Advisors LLC bought a new position in shares of Health Catalyst in the 1st quarter worth about $7,724,000. Geode Capital Management LLC increased its stake in shares of Health Catalyst by 11.4% in the 2nd quarter. Geode Capital Management LLC now owns 1,662,455 shares of the company's stock worth $6,269,000 after acquiring an additional 169,580 shares in the last quarter. Finally, Acadian Asset Management LLC increased its stake in shares of Health Catalyst by 25.1% in the 2nd quarter. Acadian Asset Management LLC now owns 1,163,785 shares of the company's stock worth $4,385,000 after acquiring an additional 233,556 shares in the last quarter. 85.00% of the stock is currently owned by institutional investors.

About Health Catalyst

Health Catalyst, Inc provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.